BIO CEO & Investor Conference 2024 | Biotechnology Innovation Organization | 26 February 2024 | New York Marriott Marquis, 1535 Broadway, New York, NY 10036, USA

The conference for biotech executives + investors
Don't miss one of the largest investor conferences in our industry where institutional investors, industry analysts, and senior executives are shaping the future investment landscape of biotechnology.

• Find and request meetings with potential partners using the BIO One-on-One Partnering™ system
• Discover the latest innovations in biotech during Company Presentations
• Hear from thought-leaders during sessions on therapeutic advancements, market outlook, and policy priorities

Conference is one of the largest investor conferences focused on established and emerging publicly traded, late-stage private biotech companies. Because our mission is to support industry-wide success, we present a broad and unbiased view of investment opportunities.

Each year the Conference provides a forum where institutional investors, industry analysts, and senior biotechnology executives have the opportunity to shape the future investment landscape of the biotechnology industry, financing promising discoveries to results in better patient outcomes.

2024 Speakers

Suchismita Acharya
Founder & CEO, AyuVis Research, Inc.

John Alam
CEO, CervoMed Inc.

Tom Alapaattikoski
CEO, Brinter Inc

Michael Aldridge
Chief Executive Officer, Focal Medical

Andrew Allen
Co-Founder, President and Chief Executive Officer, Gritstone

Gbola Amusa
Partner and CSO, Chardan Capital Markets

David Anderson
Chief Scientific Officer, Code Biotherapeutics

Lindsay Androski
President and CEO, Roivant Social Ventures

William Annett
CEO, Sustained Theraeputics

Patrick Anquetil
CEO, Portal Instruments

James Antonopoulos
Managing Director, Head of Healthcare Banking, ROTH MKM

Alex Aravanis
CEO, Moonwalk Biosciences

Phyllis Arthur
Senior Vice President, Infectious Disease & Emerging Science Policy, Biotechnology Innovation Organization (BIO)

Richard Austin
CEO, Reglagene

Shaun Bagai
CEO, RenovoRx

Joshua Bagley
CSO, a:head bio AG

Anthony Baldor
CFO and Head of Business Development, Diakonos Oncology

Jessica Ballinger
President & CEO, Lyndra Therapeutics

Dror Bashan
President & CEO, Protalix Biotheraeutics

Jared Bauer
Chief Executive Officer, Seek Labs

David Bearss
CEO, Halia Therapeutics

Ann BELIEN
Founder & CEO, Rejuvenate Biomed

Johanna Bendell
Global Head of Pharma Research and Early Development Oncology, Roche

Lew Bender
CEO, Intensity Therapeutics, Inc.

Laxminarayan Bhat
CEO, Reviva Pharmaceuticals Inc

Abhijit Bhatia
Chief Operating Officer, Rakuten Medical, Inc.

Sulagna Bhattacharya
CEO, Nanoscope Therapeutics

Oded Biran
CEO, NeuroDex, Inc.

Greg Bosch
Chairman & CEO, Panavance Therapeutics Inc.

Jacques Bouchy
EVP Investor Relations and Business Development, Kineta

Soren Bregenholt
CEO, Alligator Bioscience

Robert Brooks
Chief Executive Officer, Radiance Biopharma

Karen Brunke, PhD
Executive Vice President, Corporate & Business Development, Jaguar Health, Inc.

Chris Cardon
CEO, Ziphius

Jeffrey Carper
Managing Partner, Gentas Biotechnology

Jaden Hyungseok Chang
CEO, ZTI Biosciences

Junkeun Chang
Founder & BOD chairman, supernova bio Co. Ltd.

Jennifer Cheng
Co-Founder & CEO, PTM Therapeutics, Inc.

Elaine Cheung
Moonwalk Biosciences

Jennifer Chow
CEO and Managing Director, Chimeric Therapeutics

Eddie Chung
CEO, Coastar Therapeutics Inc.

Jeffrey Cleland
Chairman, CEO & President, Ashvattha Therapeutics, Inc.

Carter Cliff
CEO, Papillon Therapeutics, Inc.

J. Robert Coleman
CEO, Hervolution, ApS

Ryan Confer
Chief Financial Officer, Genprex, Inc.

Mikael Contrastin
EG 427

Mads Dalsgaard
Chief Executive Officer, Cureteq AG

Lucas Decuypere
CEO, Allegro

David Dodd
Chairman & CEO, GeoVax Labs, Inc.

Matt Duffy
NRx Pharma

Lynn Durham
CEO & Founder, STALICLA

Kevin Engholdt
CEO and Founder, Infinitum Health, LLC

Yusuf Erkul
CEO, Kernal Biologics

David Esposito
CEO, ONL Therapeutics, Inc.

Erin Estey Hertzog
Partner, Foley Hoag

Robert Fallon
President & CEO, Promontory Therapeutics Inc.

Howard Fillit
Co-Founder and Chief Science Officer, Alzheimer’s Drug Discovery Foundation (ADDF)

Alexandra Forbes
President and Chief Executive Officer, MeiraGTx

Marisa Frackman
Sapience Therapeutics, Inc.

John Frangioni
CEO, Curadel Surgical Innovations, Inc.

Javeed Froozan
Vice President, Business Development & Strategic Alliances, The Leukemia & Lymphoma Society

Ian Frost
ICR Westwicke

Vipin Garg
President and Chief Executive Officer, Altimmune

Steve Glover
Chairman and CEO, ZyVersa Therapeutics, Inc

Asthika Goonewardene
Managing Director, Equity Research, Truist Securities

Kevin Green
COO, Elsie Bio

Johanna Rodriguez Grossman
Head of Healthcare & Life Sciences, Capital Markets, New York Stock Exchange

Shalabh Gupta
CEO, Unicycive Therapeutics

Don Haut
Chief Business Officer, EG 427

Kate Haviland
CEO, Blueprint Medicines

Amir Hefni
CEO, Resolution Therapeutics

James Helliwell
CEO, Eupraxia Pharmaceuticals

William Ho
President & CEO, IN8bio

Earle Holesapple
CEO, SciTech Development

Jack HU
CEO, Calissa Therapeutics

Janet Huie
CSO, Co-Founder, Jan Biotech, Inc.

Ellen Hukkelhoven
Head of Biotechnology Investments, Perceptive Advisors

Randall Hyer
CEO, Merlin Biotech, Inc.

Neil Inala
CEO, Nobias Therapeutics

Jon Isaacsohn
Founder & Chief Executive Officer, CinFina

CA (Oscar) Izeboud
CEO, Scenic Biotech

Brian Jahns
President & Chief Operating Officer, Vasomune Therapeutics inc

Jonathan Javitt
Chairman and Chief Scientist, NRx Pharma

Alan Joslyn
Chief Executive Officer, Inimmune Inc.

Petrina Kamya
Vice President and Global Head of AI Platforms, Insilico Medicine, President, Insilico Medicine Canada

Barry Kappel
President, CEO & Founder, Sapience Therapeutics

Rashida Karmali
Chief Executive Officer & President, Tactical Therapeutics,Inc

Anna Kazanchyan
Founder and Chief Executive Officer, Saghmos Therapeutics

Hans Keirstead
Chairman of the Board, Immunis, Inc.

Hans Keirstead
Chairman & CEO, AiVita Biomedical, Inc.

Neal Koller
CEO, Alphyn Biologics

Maria Kondratyev
CEO, Aeterna. Therapeutics

Pawel Krysiak
President & CEO, Jaya Biosciences Inc.

Maximiliano Kunze Küllmer
Business Co-founder, EVast Bio Inc.

Alexander Lai
Chief Technology Officer (CTO), Vincogen Corporation

Laura Lande-Diner
President & CBO, Satellite Bio

Seth Lederman
Co-Founder, CEO & Chairman, TONIX Pharmaceuticals

Bo Liang
Chairman & CEO, IVIEW Therapeutics Inc.

Karsten Lindhardt
CEO, Biograil

Jeff Liter
CEO, Luminary Therapeutics, Inc.

Geulah Livshits
Senior Research Analyst, Chardan Capital Markets

Ted Love
Chair, BIO Board of Directors

Brent Lucas
Chief Executive Officer, Envoy Medical, Inc.

Tom Lytle
Vice President, Cognigenics

George Magrath
CEO, Ocuphire

Ricardo Mancebo
Founder & CEO, Genendeavor

Glenn Markov
COO, Rejuvenation Technologies

Richard Marshall
CEO, Juvenescence

Ed Mascioli
CEO, ZWI TX

Dawn Mattoon
Chief Executive Officer, Mercy BioAnalytics

Leonard Mazur
Chief Executive Officer, Citius Pharmaceuticals

David Mazzo
President and Chief Executive Officer, Lisata Therapeutics

Jeffrey Meckler
CEO, Indaptus Therapeutics

Retsina Meyer
Head of Corporate Strategy, Delix

Michel Mommejat
Chief Innovation Officer, Genesis Healthcare

Ana Moreno
CEO, Navega Therapeutics

Timothy Morris
Board Member, Humanetics Corporation

John Murphy
Chief Policy Officer, BIO

Gabe Musso
Co-Founder and CSO, BioSymetrics

Shankar Musunuri
Chairman, CEO, Co-Founder, Ocugen, Inc.

Karthik Musunuri
CEO & Co-Founder, Avstera Therapeutics Corp.

Michael Nally
CEO Partner and Chief Executive Officer of Generate, Biomedicines, Flagship Pioneering

Sara Nayeem
Executive Vice President, Investments, Enavate Sciences

George NG
Chief Executive Officer, Processa Pharmaceuticals, Inc.

Joe Nolan
Chief Executive Officer, Jaguar Gene Therapy

Jonathan Norris
Managing Director, HSBC Innovation

Christoph Nowak
Chief Medical and Business Officer, Diamyd Medical

Sanghamitra Mobassarah Nusrat Jahan
Founder, CEO, CyGenica

Kevin O'Neill
Sr. Vice President, Uvax Bio, LLC

Michele Oshman
Vice President, External Affairs, BIO

John Oyler
CEO, BeiGene

Spyros Papapetropoulos
President and CEO, Bionomics Inc

John Pavlidis
CEO, EosDx Inc.

Lars Prestegarden
CEO, Cytovation

Bruce Pritchard
CEO, Caledon Bioscience Inc.

Cynthia Pussinen
Chief Executive Officer, Sernova Corp.

Yasmeen Rahimi
Senior Research Analyst, Piper Sandler

Swayampakula Ramakanth
Managing Director, Senior Healthcare Analyst, H.C. Wainwright

Deborah Rathjen
CEO, Carina Biotech

Susan Roberts
Founder, Roberts Communications

James Rolke
CEO, Revelation Biosciences Inc

Spiro Rombotis
President and CEO, Cyclacel Pharmaceuticals, Inc.

Robert Ryan
CEO, Innova Therapeutics

Catherine Sabatos-Peyton
CEO, Larkspur Biosciences

James Sapirstein
President, Chairman, and CEO, First Wave BioPharma, Inc.

Liz Schwarzbach
Chief Business Officer, BigHat Biosciences

Lynn Seely
President and CEO, Lyell Immunopharma

Chadé Severin
Partner, Mergers and Acquisitions, Skadden

Susan Severin
Code Biotherapeutics

Dhvanit Shah
President and CEO, Garuda Therapeutics

Scott Shively
CEO, Bexion Pharmaceuticals

Timothy Siegert
COO, Allyx Therapeutics

Erika Siren
CEO, Seragene Therapeutics

Ian Sobel
Chief Executive Officer, BioHarvest Sciences

Ryan Starkes
Partner, Life Sciences Practice Leader & Raleigh Market Leader, Centri Consulting

Adam Stone
Chief Investment Officer & Head of Research, Perceptive Advisors

Mayukh Sukhatme
President & Chief Investment Officer, Roivant Sciences

Eddie Sullivan
Co-Founder, President & CEO, SAB Biotherapeutics

Paul Peter Tak
President & CEO, Candel Therapeutics

Joe Talamo
Intensity Therapeutics, Inc.

David Thomas
Senior Vice President, Industry Research, Biotechnology Innovation Organization (BIO)

Wenzhi Tian
Founder, Chairman & CEO, ImmuneOnco Biopharmaceuticals (Shanghai) Inc.

Youren Tong
Head of R&D, Kanglin Biotechnology (Hangzhou) Co., Ltd.

Robert Towarnicki
President & CEO, SIRPant Immunotherapeutics Inc.

Nolan Townsend
CEO and Director, LEXEO

Arda Ural
Americas Leader for Life Sciences and Healthcare, EY (Ernst & Young)

Raymond Vennare
Chief Executive Officer, Predictive Oncology

Ajay Vishwakarma
Founder and CEO, Cell BioEngines, Inc

Stella Vnook
CEO, Likarda

Greg Vontz
CEO, Leapfrog Bio

Kate Walsh
Managing Director, Life Science and Healthcare, HSBC Bank USA

Joshua Wang
Founder/CEO, Washington DC

Michael Ward
Vice President of Public Policy and Government Relations, Alliance for Aging Research

James Wassil
COO, Vaxcyte

Stan Watowich
CEO, Ridgeline Therapeutics

Michael Webb
CEO, Epion Therapeutics, Inc.

STEFAN WEBER
CEO, Newron Pharmaceuticals SpA

Rick Weissenstein
Managing Director, Washington Research Group - Health Care Services & Pharmaceutical Policy, TD Cowen Washington Research Group

Martin Welschof
CEO, BioInvent International

Brian Windsor
President and COO, Aileron Therapeutics

Genine Winslow
CEO, Editpep

Simon Xi
CEO, Rgenta Therapeutics

Alethia Young
Chief Financial Officer, Bicycle Therapeutics

Ashley Zehnder
Founder and CEO, Fauna Bio

Minghong Zhong
CEO, GeneLancet Biosciences, Inc.

Thomas Zindrick
President and CEO, Genelux Corporation

2024 Sponsors

SUPPORTING BANK SPONSOR:
• Chardan

PREMIER SPONSORS:
• Bio Harvest
• NYC/EDC
• Roth MKM
• Skadden

CONFERENCE SPONSORS:
• Blaise Group International
• Chubb
• The Money Channel
• Novotech
• Nucleus Network
• Scendea
• Share Vault